FDA staff questions Clovis drug?s benefit over current treatments
 

FDA staff questions Clovis drug?s benefit over current treatments
(Reuters) - The U.S. Food and Drug Administration staff reviewers on Friday questioned whether Clovis Oncology Inc's lung cancer drug was superior to existing treatments.
http://i2.wp.com/reuters.us.feedspor...f?resize=1%2C1http://feeds.feedburner.com/~ff/reut...?d=yIl2AUoC8zA http://feeds.feedburner.com/~ff/reut...ow:F7zBnMyn0Lo http://feeds.feedburner.com/~ff/reut...ow:V_sGLiPBpWU
http://feeds.feedburner.com/~r/reute...~4/IPHvIatXPY4